JOHN ZHANG: Open Payments
NPI 1295980399 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,535 in 330 payments from 41 companies in 2025. Trend: 2023 $5,748 · 2024 $7,393 · 2025 $6,535
Food & beverage: $6,480Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $607 |
| HARMONY BIOSCIENCES LLC | 11 | $430 |
| JAZZ PHARMACEUTICALS INC. | 17 | $364 |
| UCB, Inc. | 19 | $334 |
| CATALYST PHARMACEUTICALS, INC. | 11 | $326 |
| PFIZER INC. | 19 | $313 |
| Biogen, Inc. | 9 | $264 |
| SK Life Science, Inc. | 9 | $247 |
| Neurocrine BioSciences, Inc. | 12 | $242 |
| Alexion Pharmaceuticals, Inc. | 10 | $215 |
Products named: WAKIX, FYCOMPA, NURTEC ODT, INGREZZA, ULTOMIRIS, KESIMPTA, VYEPTI, XYWAV.
Industry payments across IN — which companies pay providers there.
